![](/img/cover-not-exists.png)
Golimumab, a Human Anti-Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings
Emery, Paul, Fleischmann, Roy M., Doyle, Mittie K., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric, Churchill, Melvin, Park, Won, Pons-Estel, Bernardo, Xu, Weichun, Xu, Stephen, Wu, ZhonVolume:
65
Language:
english
Journal:
Arthritis Care & Research
DOI:
10.1002/acr.22072
Date:
November, 2013
File:
PDF, 151 KB
english, 2013